BillionToOne, Inc.
BLLN
Classement en actions
#3440
BillionToOne, Inc. is a specialized diagnostics company that innovates by... BillionToOne, Inc. is a specialized diagnostics company that innovates by precisely quantifying biological data to create advanced molecular diagnostic solutions. Central to their operations is a cutting-edge molecular counting platform, meticulously engineered to identify and measure individual DNA molecules, thereby significantly enhancing the precision of disease detection. Their product portfolio includes: UNITY Complete: A non-invasive prenatal screen that assesses a fetus's risk for aneuploidies, recessive genetic conditions, and fetal antigens, all from a simple maternal blood sample. Northstar Select: A liquid biopsy test designed to pinpoint specific mutations present in tumors, encompassing deletions, insertions, and point mutations. Northstar Response: A diagnostic tool that enables continuous tracking of cancer progression through detailed methylation assessment. Established in 2016, BillionToOne, Inc. conducts its operations from its headquarters located in Menlo Park, California.
Prix de l'action
$105.11
Dernière synchronisation: 2026-10-21
Capitalisation boursière
$4.96B
Changement (1 jour)
1.56%
Changement (1 an)
-
Pays
US
Échange BillionToOne, Inc. (BLLN)
Catégorie
Healthcare
Historique du prix de l'action pour BillionToOne, Inc. (BLLN)
Prix de clôture le plus élevé : $100.39 le 2026-10-01
Prix de clôture le plus bas : $106.24 le 2025-11-01
Prix de clôture le plus bas : $106.24 le 2025-11-01
Historique du prix de l'action de BillionToOne, Inc. de 2025 à 2026
Performance annuelle du prix de l'action
| Année | Performance |
|---|---|
| 2026 (TTM) | -1.87% |
| 2025 | 0.00% |
Prix de l'action pour des entreprises similaires ou concurrentes
| Entreprise | Prix de l'action | Variation 1a% | Pays |
|---|---|---|---|
| $694.53 | 22.45% |
US
|
|
| $234.00 | 7.29% |
US
|
|
| $416.01 | 121.26% |
US
|
|
| $21.16 | 49.45% |
CN
|
|
| $177.93 | 21.98% |
US
|
